🔗 Visit the ClinicalTrials.gov page for NCT02168777
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy. | Oncogene | 2015 | 0.90 |
| 2 | Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression. | Mol Cancer Ther | 2015 | 0.79 |
| 3 | Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases. | World J Gastroenterol | 2016 | 0.78 |
| 4 | Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers. | Clin Lung Cancer | 2015 | 0.75 |